Jacqueline D. Shields
Affiliations: | 2001-2004 | MRC Cancer Cell Unit | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"Jacqueline Shields"Parents
Sign in to add mentor| J Rodney Levick | grad student | ||
| David Owen Bates | grad student | 2001-2004 | Cambridge |
Children
Sign in to add trainee| Sarah Davidson | grad student | Cambridge | |
| Jennifer Harries | grad student | Cambridge |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Riedel A, Helal M, Pedro L, et al. (2022) Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma. Cancer Immunology Research. 10: 482-497 |
| Munir H, Jones JO, Janowitz T, et al. (2021) Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth. Nature Communications. 12: 683 |
| Munir H, Mazzaglia C, Shields JD. (2020) Stromal regulation of tumor-associated lymphatics. Advanced Drug Delivery Reviews |
| Munir H, Mazzaglia C, Shields JD. (2020) Stromal regulation of tumor-associated lymphatics. Advanced Drug Delivery Reviews |
| Mahata B, Pramanik J, van der Weyden L, et al. (2020) Tumors induce de novo steroid biosynthesis in T cells to evade immunity. Nature Communications. 11: 3588 |
| Davidson S, Efremova M, Riedel A, et al. (2020) Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth. Cell Reports. 31: 107628 |
| Riedel A, Shorthouse D, Haas L, et al. (2016) Tumor-induced stromal reprogramming drives lymph node transformation. Nature Immunology |
| Hu Y, Gale M, Shields J, et al. (2012) Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leukemia & Lymphoma. 53: 130-8 |
| Shields JD. (2011) Lymphatics: at the interface of immunity, tolerance, and tumor metastasis. Microcirculation (New York, N.Y. : 1994). 18: 517-31 |
| Siders WM, Shields J, Garron C, et al. (2010) Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models. Leukemia & Lymphoma. 51: 1293-304 |